RxDoctor Payments Data

Colleen Lizewski

Medical · Frackville, PANPI 1760804512

Payments from drug & device makers

$8,921in general payments, 2019–2025

Across 500 payments — averaging $17.84 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • AbbVie$2K
  • AstraZeneca$1K
  • Lilly USA, LLC$855
  • ITI, Inc. (d/b/a Intra-cellular Therapies, Inc.)$657
  • GSK$649
  • Otsuka America Pharmaceutical, Inc.$521
  • plus $3K from 21 others

What the payments were for

  • Food & beverage$8,85699%
  • Education$651%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$8,921 in reported general payments places this provider in the 95th percentile of 2,594 medical providers in Pennsylvania.

See all medical providers in Pennsylvania

Most prescribed under Part D

DrugClaimsCost to plans & patients
TrulicityDulaglutide52$53,423
Trelegy ElliptaFluticasone/Umeclidin/Vilanter57$49,413
EliquisApixaban46$43,858
JardianceEmpagliflozin30$37,342
FarxigaDapagliflozin Propanediol33$35,328
OzempicSemaglutide14$27,811
Breztri AerosphereBudesonide/Glycopyr/Formoterol26$21,839
Spiriva RespimatTiotropium Bromide18$13,728
LinzessLinaclotide11$13,166
Albuterol Sulfate HfaAlbuterol Sulfate84$3,514
Buprenorphine-NaloxoneBuprenorphine Hcl/Naloxone Hcl13$2,118
Gabapentin102$1,897
Fluticasone-SalmeterolFluticasone Propion/Salmeterol13$1,531
FenofibrateFenofibrate Nanocrystallized49$1,337
Atorvastatin Calcium141$1,093

Paid to pharmacies, not to this prescriber.

Companies that both paid and supply prescribed drugs

These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.

CompanyPaid to this providerPart D cost of their drugs
AstraZenecaFarxiga, Breztri Aerosphere$1,374$57,16759 claims
Lilly USA, LLCTrulicity$855$53,42352 claims
Boehringer IngelheimJardiance, Spiriva Respimat$177$51,07048 claims
GSKTrelegy Ellipta$649$49,41357 claims
PfizerEliquis$28$43,85846 claims
Novo NordiskOzempic$44$27,81114 claims
AbbVieLinzess$1,668$13,16611 claims

Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 95th percentile of 2,594 medical providers in Pennsylvania.

Other medical in Frackville

See the full list for Pennsylvania

Where these figures come from

Is this you, or does something look wrong? →